
Alert: New Earnings Report (11/2/23)-Celldex Therapeutics Inc (NASDAQ: CLDX).
For its third fiscal quarter (ending September 30), Celldex Therapeutics Inc (NASDAQ: CLDX) has reported E.P.S. of $-0.81 compared to $-0.57 a year ago. This performance was $-0.15 short of the consensus estimate of $-0.66. […]